Center-Authored Papers

Filters: Author is Warren, Terri  [Clear All Filters]
2017
Bernstein DI, Wald A, Warren T, Fife K, Tyring S, Lee P, Van Wagoner N, Magaret A, Flechtner JB, Tasker S et al..  2017.  Therapeutic Vaccine for Genital Herpes Simplex Virus-2 Infection: Findings from a Randomized Trial.. The Journal of infectious diseases. Abstract
Agyemang E, Le Q-A, Warren T, Magaret AS, Selke S, Johnston C, Jerome KR, Wald A.  2017.  Performance of Commercial Enzyme-Linked Immunoassays for Diagnosis of Herpes Simplex Virus-1 and Herpes Simplex Virus-2 Infection in a Clinical Setting.. Sexually transmitted diseases. Abstract
2016
Edlefsen PT, Birkmann A, Huang M-L, Magaret CA, Kee JJ, Diem K, Goldner T, Timmler B, Stoelben S, Ruebsamen-Schaeff H et al..  2016.  No Evidence of Pritelivir Resistance Among Herpes Simplex Virus Type 2 Isolates After 4 Weeks of Daily Therapy.. The Journal of infectious diseases. 214(2):258-264. Abstract
Wald A, Timmler B, Magaret A, Warren T, Tyring S, Johnston C, Fife K, Selke S, Huang M-L, Stobernack H-P et al..  2016.  Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial.. JAMA. 316(23):2495-2503. Abstract
2014
Wald A, Corey L, Timmler B, Magaret A, Warren T, Tyring S, Johnston C, Kriesel J, Fife K, Galitz L et al..  2014.  Helicase-primase inhibitor pritelivir for HSV-2 infection.. The New England journal of medicine. 370(3):201-10. Abstract
2011
Wald A, Koelle DM, Fife K, Warren T, Leclair K, Chicz RM, Monks S, Levey DL, Musselli C, Srivastava PK.  2011.  Safety and immunogenicity of long HSV-2 peptides complexed with rhHsc70 in HSV-2 seropositive persons.. Vaccine. 29(47):8520-9. Abstract
Phipps W, Saracino M, Magaret AS, Selke S, Remington M, Huang M-L, Warren T, Casper C, Corey L, Wald A.  2011.  Persistent genital herpes simplex virus-2 shedding years following the first clinical episode.. The Journal of infectious diseases. 203(2):180-7. Abstract
Tronstein E, Johnston C, Huang M-L, Selke S, Magaret AS, Warren T, Corey L, Wald A.  2011.  Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection.. JAMA : the journal of the American Medical Association. 305(14):1441-9. Abstract
2010
Koelle DM, Magaret AS, Warren T, Schellenberg GD, Wald A.  2010.  APOE genotype is associated with oral herpetic lesions but not genital or oral herpes simplex virus shedding.. Sexually transmitted infections. 86(3):202-6. Abstract
2008
Koelle DM, Magaret AS, McClurkan CL, Remington ML, Warren T, Teofilovici F, Wald A.  2008.  Phase I dose-escalation study of a monovalent heat shock protein 70-herpes simplex virus type 2 (HSV-2) peptide-based vaccine designed to prime or boost CD8 T-cell responses in HSV-naïve and HSV-2-infected subjects.. Clinical and vaccine immunology : CVI. 15(5):773-82. Abstract